Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomic Testing in Patients with Metastatic Castration-resistant Prostate Cancer: A Pragmatic Guide for Clinicians
Axel S. Merseburger, Nick Waldron, María J. Ribal, et al.
European Urology (2021) Vol. 79, Iss. 4, pp. 519-529
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study
Wassim Abida, David Campbell, Akash Patnaik, et al.
European Urology (2023) Vol. 84, Iss. 3, pp. 321-330
Open Access | Times Cited: 42
The promising role of new molecular biomarkers in prostate cancer: from coding and non-coding genes to artificial intelligence approaches
Ana Paula Alarcón-Zendejas, Anna Scavuzzo, Miguel Ángel Jiménez-Ríos, et al.
Prostate Cancer and Prostatic Diseases (2022) Vol. 25, Iss. 3, pp. 431-443
Open Access | Times Cited: 67
Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations
Paweł Rajwa, Fahad Quhal, Benjamin Pradère, et al.
Nature Reviews Urology (2023) Vol. 20, Iss. 4, pp. 205-216
Closed Access | Times Cited: 20
Prostate cancer: Molecular aspects, consequences, and opportunities of the multifocal nature
Rolf I. Skotheim, Mari Bogaard, Kristina Totland Carm, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189080-189080
Open Access | Times Cited: 6
Disparities in germline testing among racial minorities with prostate cancer
Nicole Weise, Justin Shaya, Juan Javier‐Desloges, et al.
Prostate Cancer and Prostatic Diseases (2021) Vol. 25, Iss. 3, pp. 403-410
Open Access | Times Cited: 35
DNA repair deficiency as circulating biomarker in prostate cancer
Martina Catalano, Daniele Generali, Marta Gatti, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 13
Circular RNA ITCH: An Emerging Multifunctional Regulator
Kaixin Su, Yi Qiao, Xiaohan Dai, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 359-359
Open Access | Times Cited: 17
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study
Chiara Casadei, Emanuela Scarpi, Vincenza Conteduca, et al.
European Urology Open Science (2024) Vol. 61, pp. 44-51
Open Access | Times Cited: 3
PARP inhibitors for metastatic castration-resistant prostate cancer: Biological rationale and current evidence
Michał Bieńkowski, Bartłomiej Tomasik, Marcin Braun, et al.
Cancer Treatment Reviews (2022) Vol. 104, pp. 102359-102359
Closed Access | Times Cited: 14
Radiogenomics Analysis Linking Multiparametric MRI and Transcriptomics in Prostate Cancer
Catarina Fernandes, Annekoos Schaap, J A Kant, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3074-3074
Open Access | Times Cited: 8
Molecular Characterization of Prostate Cancers in the Precision Medicine Era
Emilio Francesco Giunta, Laura Annaratone, Enrico Bollito, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4771-4771
Open Access | Times Cited: 19
Molecular Genetics of Prostate Cancer and Role of Genomic Testing
Dilara Akhoundova, Felix Y. Feng, Colin C. Pritchard, et al.
Surgical pathology clinics (2022) Vol. 15, Iss. 4, pp. 617-628
Open Access | Times Cited: 11
Dissecting the Hormonal Signaling Landscape in Castration-Resistant Prostate Cancer
Fabrizio Fontana, Patrízia Limonta
Cells (2021) Vol. 10, Iss. 5, pp. 1133-1133
Open Access | Times Cited: 15
A novel signature based on pyroptosis-related genes for predicting prognosis and treatment response in prostate cancer patients
Xi Xiao, Jianpeng Li, Shun Wan, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 10
Pembrolizumab in mCRPC – Combination therapies as breakthrough to success?
Stefan Plas, Andreas Pircher, Isabel Heidegger
Current Opinion in Urology (2023) Vol. 33, Iss. 6, pp. 458-471
Closed Access | Times Cited: 5
Case report: Exceptional and durable response to Radium-223 and suspension of androgen deprivation therapy in a metastatic castration-resistant prostate cancer patient
Francesca Zacchi, Joan Carles, Macarena González, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
NIR-triggerable self-assembly multifunctional nanocarriers to enhance the tumor penetration and photothermal therapy efficiency for castration-resistant prostate cancer
Shuqiang Li, Yan Ma, Chao Ma, et al.
Discover Nano (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 3
Real-World Treatment Patterns Among French Patients With Metastatic Castration-Resistant Prostate Cancer Under Abiraterone or Enzalutamide
Lucie‐Marie Scailteux, S. Vincendeau, Gwénaëlle Gravis, et al.
Clinical Genitourinary Cancer (2023) Vol. 21, Iss. 5, pp. e362-e369
Open Access | Times Cited: 3
Identification of molecular subtypes and a prognostic signature based on chromatin regulators related genes in prostate cancer
Hangbin Ma, Cheng Zhou, Jianchao Ge, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 2
Treatments and challenges in advanced prostate cancer
Theodore Stewart Gourdin, Arash Velayati
Current Opinion in Oncology (2023) Vol. 35, Iss. 3, pp. 200-205
Closed Access | Times Cited: 2
Comparing efficacy of first-line treatment of metastatic castration resistant prostate cancer: a network meta-analysis of randomized controlled trials
Yang Liu, Xianzhong Deng, Zhi Wen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Building confidence in circulating tumour DNA assays for metastatic castration-resistant prostate cancer
Sarah W.S. Ng, Alexander W. Wyatt
Nature Reviews Urology (2021) Vol. 18, Iss. 5, pp. 255-256
Closed Access | Times Cited: 5
Recent Insights on Genetic Testing in Primary Prostate Cancer
Mona Kafka, C. Surcel, Isabel Heidegger
Molecular Diagnosis & Therapy (2021) Vol. 25, Iss. 4, pp. 425-438
Open Access | Times Cited: 5
Therapiesequenzen und –dauer beim mCRPC: Eine retrospektive Aufarbeitung der Lübecker mCRPC-Kohorte
Marten Müller, Semih Sarcan, Anne Offermann, et al.
Aktuelle Urologie (2024)
Closed Access
Novel device for dividing core needle biopsy specimens to provide paired mirror image-like tissues for genetic and pathological tests
Yuichi Nakamura, Keisuke Tsuji, Takumi Shiraishi, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top